Treatment of canine sarcoptic mange with afoxolaner (NexGard®) and afoxolaner plus milbemycin oxime (NexGard Spectra®) chewable tablets: efficacy under field conditions in Portugal and Germany [PDF]
The efficacy of NexGard® and NexGard Spectra® against sarcoptic mange in dogs was evaluated in a clinical field study. Skin scrapings from dogs presenting signs suggestive of sarcoptic mange were examined to confirm infestation.
Hampel Verena +4 more
doaj +4 more sources
Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area [PDF]
Background Leishmania infantum and Dirofilaria immitis are among the most important canine vector-borne pathogens (CVBPs) of zoonotic concern in Europe.
Rossella Panarese +5 more
doaj +3 more sources
Efficacy of a combination of esafoxolaner, eprinomectin and praziquantel (NexGard® Combo) against Thelazia callipaeda in naturally infected cats [PDF]
This clinical study assessed the efficacy of a topical combination of esafoxolaner, eprinomectin and praziquantel (NexGard® Combo) in treating cats naturally infected with the eyeworm Thelazia callipaeda (Nematoda, Thelaziidae).
Di Cesare Angela +6 more
doaj +3 more sources
Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe [PDF]
Background A multi-centre field trial was conducted to evaluate the efficacy of afoxolaner based chewables (NexGard® or NexGard Spectra®) for the treatment of generalised demodicosis caused by Demodex canis in dogs under field conditions in France, Italy
Wilfried Lebon +16 more
doaj +3 more sources
Preventive efficacy of six monthly doses of NexGard® PLUS or Simparica Trio® against a macrocyclic lactone-resistant isolate (JYD-34) of Dirofilaria immitis and of a single dose of NexGard PLUS against a susceptible isolate [PDF]
Background Two studies were conducted assessing the efficacy of NexGard® PLUS (NP) in preventing heartworm disease. Study 1 evaluated the efficacy of six monthly doses of NP or Simparica Trio® (ST) against a macrocyclic lactone-resistant isolate of ...
Joseph Prullage +6 more
doaj +3 more sources
Prevention of the transmission of Babesia rossi by Haemaphysalis elliptica in dogs treated with Nexgard® [PDF]
This experimental study aimed to determine the efficacy of Afoxolaner (NexGard®) to prevent Babesia rossi transmission by Haemaphysalis elliptica ticks on dogs. The study included three groups of seven dogs each.
Beugnet Frederic +2 more
doaj +3 more sources
Afoxolaner (NexGard®) in pet snakes for the treatment and control of Ophionyssus natricis (Mesostigmata: Macronyssidae) [PDF]
Background Ophionyssus natricis is the main species of mite that infests captive reptiles. High infestations may result in the host experiencing general discomfort and deleterious effects, even death. Moreover, O.
Jairo Alfonso Mendoza-Roldan +9 more
doaj +3 more sources
Efficacy of afoxolaner (NexGard®) against natural infestations with Trichodectes canis in dogs under field conditions [PDF]
Background Trichodectes canis is a small chewing louse found globally that primarily infests dogs. Limited information is available on the efficacy of isoxazolines against infestation with the chewing louse.
Andrei Daniel Mihalca +4 more
doaj +2 more sources
Comparative efficacy of six monthly doses of Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) versus NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets) against a macrocyclic lactone-resistant Dirofilaria immitis isolate in dogs [PDF]
Background The emergence of macrocyclic lactone (ML)-resistant Dirofilaria immitis highlights the need for informed and considered use of currently available heartworm preventives.
Jessica Rodriguez +7 more
doaj +2 more sources
Efficacy of oral afoxolaner and a combination of afoxolaner, moxidectin, and pyrantel against Amblyomma maculatum in dogs [PDF]
Background Amblyomma maculatum is a tick with a broad host range that is undergoing an expansion of its range within the USA. When feeding the predilection sites on the host are the head and ears and due to the long mouthparts, it can cause significant ...
Joseph Prullage +5 more
doaj +2 more sources

